Central Retinal Vein Occlusion
📧 Sign up to get email alerts when something new happens for Central Retinal Vein Occlusion.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO) [Phase 3]
Phase 3 trial evaluating the efficacy and safety of intravitreal ranibizumab versus dexamethasone implant for central retinal vein occlusion…
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)
Post-market surveillance results for OZURDEX (dexamethasone intravitreal implant) in branch retinal vein occlusion and central retinal vein …
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy [Phase 4]
Update on a Phase 4 trial evaluating intravitreal aflibercept (Eylea) for persistent macular edema due to central retinal vein occlusion in …
-
CLINICAL_TRIALS trial_result · 2014-08-13Clinical Trial Update: Hemodilution Versus Ranibizumab in Early-onset Central Retinal Vein Occlusion [Phase 4]
This ClinicalTrials.gov update notes the completion of a Phase 4 trial comparing hemodilution with ranibizumab for early-onset Central Retin…
-
CLINICAL_TRIALS trial_result · 2014-06-30Clinical Trial Update: A Study of a Sustained Release Fluocinolone Implant for Treatment of Central Retinal Vein Occlusion [NA]
This update summarizes results from a trial investigating a sustained-release fluocinolone implant for central retinal vein occlusion.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-06-25Clinical Trial Update: Ziv-aflibercept in Eyes With Retinal Diseases and Poor Vision-phase I [Phase 1]
Phase I clinical trial of Ziv-aflibercept for retinal diseases, including age-related macular degeneration and central retinal vein occlusio…
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival [NA]
A completed trial compared topical versus subconjunctival anesthesia for intravitreal injections in AMD, CRVO, and DME. Results were posted …
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: Predictive Factors of Ranibizumab Treatment in Macular Edema With CRVO [NA]
This clinical trial update describes factors that may predict how patients with macular edema due to Central Retinal Vein Occlusion respond …
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: Lucentis for Central Retinal Vein Occlusion (CRVO) [Phase 1]
This document reports the completion of a Phase 1 trial evaluating Lucentis (ranibizumab) for central retinal vein occlusion.
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: Lucentis for Macular Edema Associated With Central Retinal Vein Occlusion [Phase 1]
A Phase 1 trial evaluating Lucentis (ranibizumab) for macular edema due to Central Retinal Vein Occlusion has completed its Phase 1 study.
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO) [Phase 3]
This entry reports the completion of a Phase 3 trial evaluating VEGF Trap-Eye (aflibercept) for macular edema due to central retinal vein oc…
-
CLINICAL_TRIALS trial_result · 2012-11-22Clinical Trial Update: Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO) [Phase 3]
A Phase 3 trial sponsored by Bayer evaluated VEGF Trap-Eye (aflibercept) for central retinal vein occlusion; results have been posted after …
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: Retinal Ischemia in Central Retinal Vein Occlusion, and the Effects of Treatment With Intravitreal Ranibizumab
The trial studied retinal ischemia in central retinal vein occlusion and the effects of intravitreal ranibizumab treatment.
-
CLINICAL_TRIALS trial_result · 2012-09-03Clinical Trial Update: The Effectiveness of Intravitreal Avastin Injection for CRVO
This clinical trial update assesses the effectiveness of intravitreal bevacizumab (Avastin) injections for central retinal vein occlusion. T…
-
CLINICAL_TRIALS trial_result · 2012-01-19Clinical Trial Update: A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO [Phase 3]
Phase 3 randomized trial comparing ranibizumab to sham for macular edema caused by central retinal vein occlusion; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-01-10Clinical Trial Update: Study to Assess the Safety and Tolerability of a Single Administration of FOV2302 (Ecallantide) in Patients With Macular Edema Associated With Central Retinal Vein Occlusion [Phase 1]
A Phase 1 trial evaluating the safety and tolerability of a single administration of FOV2302 (ecallantide) in macular edema associated with …
-
CLINICAL_TRIALS trial_result · 2011-11-22Clinical Trial Update: Bevacizumab for Central Retinal Vein Occlusion Study [Phase 3]
This entry indicates that a Phase 3 trial of bevacizumab for central retinal vein occlusion has completed.
-
CLINICAL_TRIALS trial_result · 2011-03-18Clinical Trial Update: Impact of Lucentis on Psychological Morbidity in Patients With Retinal Vein Occlusion [Phase 1]
Phase 1 trial update examining whether Lucentis (ranibizumab) influences psychological morbidity, including depression, in patients with ret…
-
CLINICAL_TRIALS trial_result · 2011-03-04Clinical Trial Update: Radial Optic Neurotomy in Central Retinal Vein Occlusion : a Randomized Trial [NA]
A randomized trial evaluating radial optic neurotomy for central retinal vein occlusion has been terminated; no results are reported in this…
-
CLINICAL_TRIALS trial_result · 2011-02-25Clinical Trial Update: A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE) [Phase 3]
Phase 3 CRUISE study evaluating ranibizumab for macular edema due to central retinal vein occlusion showed efficacy and safety; results were…
-
CLINICAL_TRIALS trial_result · 2010-05-14Clinical Trial Update: Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of Lucentis (ranibizumab) for macular edema associated with central retinal vein o…
-
CLINICAL_TRIALS trial_result · 2010-01-22Clinical Trial Update: Triamcinolone or Bevacizumab for Central Retinal Vein Occlusion With Poor Vision [NA]
This clinical trial update indicates a completed study comparing Triamcinolone and Bevacizumab for central retinal vein occlusion with poor …
-
CLINICAL_TRIALS trial_result · 2009-10-30Clinical Trial Update: The ROVO Study: Radial Optic Neurotomy for CVO [Phase 2, Phase 3]
The ROVO study evaluating Radial Optic Neurotomy for Central Retinal Vein Occlusion has completed its Phase 2 and Phase 3 program.
-
CLINICAL_TRIALS trial_result · 2008-06-25Clinical Trial Update: Atorvastatin for the Treatment of Retinal Vein Occlusion [Phase 3]
Phase 3 clinical trial evaluating atorvastatin for retinal vein occlusion; the update does not report results and the trial status is unknow…
-
CLINICAL_TRIALS trial_result · 2007-05-07Clinical Trial Update: Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.). [Phase 2]
Phase 2 open-label trial of anecortave acetate sterile suspension (15 mg) for treatment of rubeosis iridis related to severe diabetic retino…